TESSY KADAVIL: Open Payments
NPI 1992865505 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 12 payments from 7 companies in 2025. Trend: 2023 $412 · 2024 $880 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $159 |
| Kowa Pharmaceuticals America, Inc. | 2 | $139 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Sumitomo Pharma America, Inc. | 1 | $122 |
| Eisai Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Indivior Inc. | 3 | $79 |
Products named: BRIXADI, ZORYVE, FANAPT, GEMTESA, Leqembi, CAPLYTA, SUBLOCADE.
Industry payments across TX — which companies pay providers there.
